Elinor Ben-Menachem

• Drug arrows in the quiver-antiseizure, antiepileptic and neuroprotective medication: Treatment and future aspects. A focused review

  Elinor Ben-Menachem
  Seizure - 2025
• Digital clinics for diagnosing and treating migraine

  Johan Nyberg, Rikard Rosenbacke, Elinor Ben-Menachem
  CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE - 2024
• Therapeutic strategies during cenobamate treatment initiation: Delphi panel recommendations

  Bernhard J. Steinhoff, Elinor Ben-Menachem, Pavel Klein, Jukka Peltola, Bettina Schmitz, Rhys H. Thomas, Vicente Villanueva
  THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS - 2024
• Mood disorders in adults with epilepsy: a review of unrecognized facts and common misconceptions

  Andres M. Kanner, Rohit Shankar, Nils G. Margraf, Bettina Schmitz, Elinor Ben-Menachem, Josemir W. Sander
  ANNALS OF GENERAL PSYCHIATRY - 2024
• Cenobamate in refractory epilepsy: Overview of treatment options and practical considerations

  Bettina Schmitz, Simona Lattanzi, Kristl Vonck, Reetta Kälviäinen, Lina Nashef, Elinor Ben-Menachem
  Epilepsia Open - 2023
• The burden of chronic drug-refractory focal onset epilepsy: Can it be prevented?

  Elinor Ben-Menachem, B. Schmitz, R. Kälviäinen, R. H. Thomas, P. Klein
  Epilepsy & Behavior - 2023
• Onset of efficacy and adverse events during Cenobamate titration period

  B. J. Steinhoff, Elinor Ben-Menachem, C. Brandt, I. G. Morales, W. E. Rosenfeld, E. Santamarina, J. M. Serratosa
  Acta Neurologica Scandinavica - 2022
• A post-approval observational study to evaluate the safety and tolerability of perampanel as an add-on therapy in adolescent, adult, and elderly patients with epilepsy

  M. Maguire, Elinor Ben-Menachem, A. Patten, M. Malhotra, L. Y. Ngo
  Epilepsy & Behavior - 2022
• Randomized controlled trial of moderate cardiovascular exercise for patients with drug-resistant epilepsy

  Sara Åkerlund, Emma Varkey, Judith Klecki, Johan Zelano, Elinor Ben-Menachem
  Epilepsy & Behavior - 2021
• Long-term safety and tolerability of lacosamide monotherapy in patients with epilepsy: Results from a multicenter, open-label trial

  Elinor Ben-Menachem, J. Dominguez, J. Szasz, C. Beller, C. Howerton, L. Jensen, C. McClung, R. Roebling, B. Steiniger-Brach
  Epilepsia Open - 2021
• A multivariable prediction model of a major treatment response for focal-onset seizures: A post-hoc analysis of Phase III trials of perampanel

  G. L. Krauss, Elinor Ben-Menachem, R. T. Wechsler, A. Patten, B. Williams, A. Laurenza, M. Malhotra
  Epilepsy Research - 2021
• Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial

  Elinor Ben-Menachem, M. Baulac, S. B. Hong, J. M. Cleveland, C. Reichel, A. L. Schulz, G. Wagener, C. Brandt
  Epilepsy Research - 2021
• Comparative analysis of the safety and tolerability of eslicarbazepine acetate in older (>= 60 years) and younger (18-59 years) adults

  E. Andermann, W. Rosenfeld, P. Penovich, J. Rogin, F. Cendes, M. Carreno, R. E. Ramsay, Elinor Ben-Menachem, H. Gama, F. Rocha, P. Soares-da-Silva, R. Tosiello, D. Blum, T. Grinnell
  Epilepsy Research - 2021
• A Phase II Randomized Trial to Explore the Potential for Pharmacokinetic Drug-Drug Interactions with Stiripentol or Valproate when Combined with Cannabidiol in Patients with Epilepsy

  Elinor Ben-Menachem, B. Gunning, C. M. A. Cabrera, K. VanLandingham, J. Crockett, D. Critchley, L. Wray, B. Tayo, G. Morrison, M. Toledo
  Cns Drugs - 2020
• Analysis of cutaneous allergic reactions in clinical trials of eslicarbazepine acetate

  J. Rogin, T. Resnick, L. Strom, Elinor Ben-Menachem, S. Kochen, D. Blum, H. Gama, P. Soares-da-Silva, Y. Li, T. Grinnell
  Acta Neurologica Scandinavica - 2020
• How can transition to adult care be best orchestrated for adolescents with epilepsy?

  Peter R. Camfield, Danielle Andrade, Carole S. Camfield, Jaime Carrizosa-Moog, Richard Appleton, Michel Baulac, Lawrence Brown, Elinor Ben-Menachem, Helen Cross, Isabelle Desguerre, Christina Grant, Hassan Hosny, Laura Jurasek, Marco Mula, Margarete Pfaefflin, Sylvain Rheims, Howard Ring, Renee A. Shellhaas, K. P. Vinayan, Elaine Wirrell, Rima Nabbout
  EPILEPSY & BEHAVIOR - 2019
• Long-term safety and efficacy of lacosamide and controlled-release carbamazepine monotherapy in patients with newly diagnosed epilepsy

  Elinor Ben-Menachem, H. P. Grebe, K. Terada, L. Jensen, T. Li, M. De Backer, B. Steiniger-Brach, T. Gasalla, M. Brock, V. Biton
  Epilepsia - 2019
• Estimating Long-Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes

  David Revesz, Victoria Fröjd, Bertil Rydenhag, Elinor Ben-Menachem
  Neuromodulation - 2018
• Perampanel in routine clinical use across Europe: Pooled, multicenter, observational data

  A. Rohracher, G. Zimmermann, V. Villanueva, I. Garamendi, J. W. Sander, T. Wehner, R. Shankar, Elinor Ben-Menachem, M. J. Brodie, M. C. Pensel, G. Di Gennaro, A. Maurousset, A. Strzelczyk, S. Rheims, A. Rácz, K. Menzler, V. Bertol-Alegre, I. García-Morales, F. J. López-González, M. Toledo, K. J. Carpenter, E. Trinka
  Epilepsia - 2018
• Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate

  B. E. Gidal, M. P. Jacobson, Elinor Ben-Menachem, M. Carreno, D. Blum, P. Soares-da-Silva, A. Falcao, F. Rocha, J. Moreira, T. Grinnell, E. Ludwig, J. Fiedler-Kelly, J. Passarell, S. Sunkaraneni
  Acta Neurologica Scandinavica - 2018
• Cannabinoids for epilepsy: What do we know and where do we go?

  Martin J Brodie, Elinor Ben-Menachem
  Epilepsia - 2018
• Effects of adjunctive eslicarbazepine acetate on serum lipids in patients with partial-onset seizures: Impact of concomitant statins and enzyme-inducing antiepileptic drugs.

  Scott Mintzer, Robert T Wechsler, Joanne B Rogin, Barry E Gidal, Matthias Schwab, Elinor Ben-Menachem, Mar Carreño, Patrício Soares da Silva, Joana Moreira, Yan Li, David Blum, Todd Grinnell
  Epilepsy research - 2018
• Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.

  Eugen Trinka, Elinor Ben-Menachem, Pedro A Kowacs, Christian Elger, Birgit Keller, Kurt Löffler, José Francisco Rocha, Patrício Soares-da-Silva
  Epilepsia - 2018
• Final safety, tolerability, and seizure outcomes in patients with focal epilepsy treated with adjunctive perampanel for up to 4 years in an open-label extension of phase III randomized trials: Study 307

  G. L. Krauss, E. Perucca, P. Kwan, Elinor Ben-Menachem, X. F. Wang, J. J. Shih, A. Patten, H. Yang, B. Williams, A. Laurenza
  Epilepsia - 2018
• Psychiatric and cognitive adverse events: A pooled analysis of three phase III trials of adjunctive eslicarbazepine acetate for partial-onset seizures

  E. Andermann, V. Biton, S. R. Benbadis, B. Shneker, A. K. Shah, M. Carreño, E. Trinka, Elinor Ben-Menachem, A. Biraben, F. Rocha, H. Gama, H. Cheng, D. Blum
  Epilepsy and Behavior - 2018
• Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies

  S. D. Shorvon, E. Trinka, B. J. Steinhoff, M. Holtkamp, V. Villanueva, J. Peltola, Elinor Ben-Menachem
  Journal of Neurology - 2017
• Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies.

  Radu Constantinescu, Fredrik Asztély, Filip Bergquist, Henrik Zetterberg, Ulf Andreasson, Markus Axelsson, Elinor Ben-Menachem, Daniel Jons, Clas Malmeström, Lars Rosengren, Kaj Blennow
  Journal of neuroimmunology - 2017
• Vagal Blocking for Obesity Control: a Possible Mechanism-Of-Action

  H. Johannessen, David Revesz, Y. Kodama, N. Cassie, Karolina P Skibicka, P. Barrett, Suzanne L. Dickson, J. Holst, J. Rehfeld, G. van der Plasse, R. Adan, B. Kulseng, Elinor Ben-Menachem, C. M. Zhao, D. Chen
  Obesity Surgery - 2017
• Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies

  Christian Elger, Mathias Koepp, Eugen Trinka, Vicente Villanueva, João Chaves, Elinor Ben-Menachem, Pedro A. Kowacs, António Gil-Nagel, Joana Moreira, Helena Gama, José Francisco Rocha, Patrício Soares-da-Silva
  CNS Neuroscience and Therapeutics - 2017
• Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies

  Elinor Ben-Menachem, R. Mameniskiene, P. P. Quarato, P. Klein, J. Gamage, J. Schiemann, M. E. Johnson, J. Whitesides, B. McDonough, K. Eckhardt
  Neurology - 2016
• Treating epileptic emergencies - pharmacological advances

  Johan Zelano, Elinor Ben-Menachem
  Expert Opinion on Pharmacotherapy - 2016
• Complications and safety of vagus nerve stimulation: 25 years of experience at a single center

  David Revesz, Bertil Rydenhag, Elinor Ben-Menachem
  Journal of Neurosurgery-Pediatrics - 2016
• Eslicarbazepine acetate for the treatment of partial epilepsy.

  Johan Zelano, Elinor Ben-Menachem
  Expert opinion on pharmacotherapy - 2016
• Epilepsy in 2015: the year of collaborations for big data

  Elinor Ben-Menachem
  Lancet Neurology - 2016
• Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis

  Radu Constantinescu, David Krysl, Filip Bergquist, Kerstin Andrén, Clas Malmeström, Fredrik Asztely, Markus Axelsson, Elinor Ben-Menachem, Kaj Blennow, Lars Rosengren, Henrik Zetterberg
  European Journal of Neurology - 2016
• Long-term adjunctive lacosamide treatment in patients with partial-onset seizures

  F. Rosenow, A. Kelemen, Elinor Ben-Menachem, C. McShea, J. Isojarvi, P. Doty
  Acta Neurologica Scandinavica - 2016
• Partial Onset Seizure Treatment with Adjunctive Lacosamide in Epileptic Adults: A Review

  Elinor Ben-Menachem
  Epilepsi - 2015
• Who is helping whom? Manuscript support and transfer of value

  R. Wechsler, R.A. Hauser, J. French, Elinor Ben-Menachem, C.W. Bazil, G.K. Bergey, G. Cascino, D. Dlugos, E. Faught, H. Fernandez, E. Fertig, J. Halford, C. Harden, J. Harvey, A. Hauser, S. Haut, S. Herman, L.J. Hirsch, R.E. Hogan, A.M. Kanner, P. Kaplan, P. Klein, D. Kremens, A. Krumholz, M.F. Lew, K. Meador, S. Mintzer, R. Pahwa, P. Penovich, J. Pollard, J. Shih, S. Shinnar, J. Sirven, M. Sperling
  Annals of Neurology - 2015
• Surgically implanted and non-invasive vagus nerve stimulation: areview of efficacy, safety and tolerability

  Elinor Ben-Menachem, David Revesz, B. J. Simon, S. Silberstein
  European Journal of Neurology - 2015
• Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: Results from phase III extension study 307

  G. L. Krauss, E. Perucca, Elinor Ben-Menachem, P. Kwan, J. J. Shih, J. F. Clément, X. Wang, M. Bagul, M. Gee, J. Zhu, D. Squillacote
  Epilepsia - 2014
• Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years

  W. Rosenfeld, N. B. Fountain, G. Kaubrys, Elinor Ben-Menachem, C. McShea, J. Isojarvi, P. Doty
  Epilepsy & Behavior - 2014
• Perampanel for adjunctive treatment of partial- onset seizures: A pooled dose- response analysis of phase III studies

  L. D. Kramer, A. Satlin, G. L. Krauss, J. French, E. Perucca, Elinor Ben-Menachem, P. Kwan, J. J. Shih, A. Laurenza, H. C. Yang, J. Zhu, D. Squillacote
  Epilepsia - 2014
• Medical management of refractory epilepsy-Practical treatment with novel antiepileptic drugs

  Elinor Ben-Menachem
  Epilepsia - 2014
• Introduction

  Elinor Ben-Menachem
  Acta Neurologica Scandinavica - 2013
• Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: Results of a 1-year open-label extension study

  Andreas Hufnagel, Elinor Ben-Menachem, Alberto A. Gabbai, Amílcar Falcão, Luis Almeida, Patricio Soares-da-Silva
  Epilepsy Research - 2013
• Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: Interim results from phase III, extension study 307

  G. L. Krauss, E. Perucca, Elinor Ben-Menachem, P. Kwan, J. J. Shih, D. Squillacote, H. Yang, M. Gee, J. Zhu, A. Laurenza
  Epilepsia - 2013
• Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies

  B. J. Steinhoff, Elinor Ben-Menachem, P. Ryvlin, S. Shorvon, L. Kramer, A. Satlin, D. Squillacote, H. Yang, J. Zhu, A. Laurenza
  Epilepsia - 2013
• Cardiovascular fitness and later risk of epilepsy A Swedish population-based cohort study

  Jenny Nyberg, Maria A I Åberg, Kjell Torén, Michael Nilsson, Elinor Ben-Menachem, Hans-Georg Kuhn
  Neurology - 2013
• A prospective, randomized, multicentre trial for the treatment of refractory status epilepticus, experiences from evaluating the effect of the novel drug candidate, NS1209

  A. Sabers, P. Wolf, A. Moller, K. Rysgaard, Elinor Ben-Menachem
  Epilepsy Research - 2013
• Issues related to development of new antiseizure treatments

  K. S. Wilcox, T. Dixon-Salazar, G. J. Sills, Elinor Ben-Menachem, H. S. White, R. J. Porter, M. A. Dichter, S. L. Moshe, J. L. Noebels, M. D. Privitera, M. A. Rogawski
  Epilepsia - 2013

More publications

We have limited the number of publications on this page. Visit GUP (The Publication Database for Gothenburg University) to find more publications.